9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 29 filers reported holding 9 METERS BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -75.0% | 10,713 | -15.0% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 12,600 | -4.4% | 0.00% | – |
| Q3 2021 | $17,000 | -34.6% | 13,185 | -43.3% | 0.00% | – |
| Q2 2021 | $26,000 | -84.7% | 23,262 | -84.0% | 0.00% | -100.0% |
| Q1 2021 | $170,000 | +71.7% | 145,724 | +20.0% | 0.00% | 0.0% |
| Q3 2020 | $99,000 | +1137.5% | 121,409 | +763.4% | 0.00% | – |
| Q2 2020 | $8,000 | – | 14,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,115,000 | $2,676,000 | 1.09% |
| Worth Venture Partners, LLC | 789,341 | $678,000 | 0.54% |
| Tri Locum Partners LP | 1,390,821 | $1,195,000 | 0.43% |
| Altium Capital Management LP | 1,264,994 | $1,087,000 | 0.41% |
| Saltoro Capital, LP | 700,000 | $601,000 | 0.30% |
| Orbimed Advisors | 25,716,755 | $22,091,000 | 0.19% |
| PERKINS CAPITAL MANAGEMENT INC | 300,000 | $258,000 | 0.17% |
| MYDA Advisors LLC | 360,000 | $309,000 | 0.09% |
| Maven Securities LTD | 750,000 | $667,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 13,000,000 | $11,167,000 | 0.02% |